MyFinsight
Home
Blog
About
Back
Income Statement
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC)
source: myfinsight.com
Comprehensive loss
-$26,233,000
Net loss
-$26,179,000
(-51.36%↓ Y/Y)
Total other
comprehensive (gain) loss
-$54,000
Other income, net
$3,131,000
(24.30%↑ Y/Y)
Loss from operations
-$29,310,000
(-47.92%↓ Y/Y)
Unrealized (gain) loss on
marketable securities
-$54,000
Total operating
expenses
$29,310,000
(47.92%↑ Y/Y)
Research and development
$12,444,000
(-4.18%↓ Y/Y)
General and
administrative
$7,462,000
(9.29%↑ Y/Y)
Impairment of long-lived
assets
$5,086,000
Restructuring expenses
$4,318,000
Back